Form 4: Nephros Inc. Director Arthur H. Amron Reports Acquisition and Disposal of Common Stock and Grant of Stock Options
SEC Form 4
Director Arthur H. Amron reports acquiring and disposing of Nephros Inc. common stock, along with the grant of new stock options.
Summary
- On January 1, 2025, Arthur H. Amron, a director of Nephros Inc., reported a transaction involving the acquisition of 22,418 shares of common stock at $0 and the disposal of 125,881 shares.
- Following the transaction, Amron beneficially owns 125,881 shares of common stock.
- Amron was also granted options to purchase 7,050 shares of common stock at an exercise price of $1.47, exercisable beginning January 1, 2025, and expiring on January 1, 2035.
- These options vest in three equal installments on January 1, 2025, January 1, 2026, and January 1, 2027.
- Amron also holds options to purchase 7,323 shares of common stock at an exercise price of $2.14, which vest in installments on May 14, 2024, May 14, 2025, and May 14, 2026.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock transactions by a company director. The grant of options is mildly positive, aligning interests, but the disposal of shares is neutral without further context.
Positives
- The grant of stock options to a director can be seen as a positive incentive, aligning the director's interests with those of the shareholders.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the director's stock transactions as an indicator of confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Vesting date for 2,441 shares of existing stock options. |
| 01/01/2025 | Date of common stock acquisition and disposal, and first vesting date for new stock options. |
| 05/14/2025 | Vesting date for 2,441 shares of existing stock options. |
| 01/01/2026 | Second vesting date for new stock options. |
| 05/14/2026 | Vesting date for 2,441 shares of existing stock options. |
| 01/01/2027 | Final vesting date for new stock options. |
| 05/14/2034 | Expiration date for existing stock options. |
| 01/01/2035 | Expiration date for new stock options. |
| 01/03/2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.